A CONSORT-Compliant, Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Purified Anthocyanin in Patients With Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is a common liver disease that can progress to cirrhosis and liver failure. Anthocyanin, a member of the flavonoid family, has been shown to ameliorate NAFLD-associated pathologies in rodents. The aim of this CONSORT-compliant pilot study is to evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pei-Wen, Chen, Feng-Xia, Li, Di, Ling, Wen-Hua, Guo, Hong-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602870/
https://www.ncbi.nlm.nih.gov/pubmed/25997043
http://dx.doi.org/10.1097/MD.0000000000000758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602870/
https://www.ncbi.nlm.nih.gov/pubmed/25997043
http://dx.doi.org/10.1097/MD.0000000000000758

Ejemplares similares